InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

Fire department tours for kids are pretty common, but for one Bismarck boy, it’s just the medicine he needed. It’s all thanks ...

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early ...